Bausch + Lomb: The Market Is Pricing The Balance Sheet, Not The Eye-Care Engine
· seekingalpha.com
Bausch + Lomb (BLCO) turnaround: Q2 2026 revenue up 9% YoY, margins expanding, cash flow strong. Learn how deleveraging and mix shift could be rerated.
I am optimistic about the future performance of Bausch + Lomb ( BLCO ), based primarily on the expectation that investors will continue to view the company as a...